We are calling for volunteers from our membership to become more involved with EMQN by taking on the role of an EQA scheme assessor. Our current vacancies are:
Lung (NSCLC) [Tissue]
PIK3CA in breast cancer
Multiple endocrine neoplasia type 2 (MEN2) - assessors with German language skills
Hereditary breast and ovarian cancer (HBOC) - assessors with Spanish and Italian language skills
Ovarian, Breast, Pancreatic and Prostate (Germline)
Ovarian and Prostate (Somatic)
Please apply below:
EMQN have recently undergone an organisational review, and as a result our membership scheme is evolving and adapting to fit in with both the needs of our members and our organisation. From 2022, we will be offering our membership at no yearly cost.
Click below to read EMQN’s full statement on our membership scheme changes!
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.
The latest news and press releases
EMQN EQA Submission Reminder - DNA Sanger Sequencing - https://t.co/1nOrdgZB40
New Best Practice Guidelines for NSCLC small specimen biomarker testing published - https://t.co/SP8P52xesd
The 2022 Provisional ILRs have been Published: Germline EQAs - https://t.co/OJToak4aDz
Are you testing for Hereditary Amyloidosis? - https://t.co/ZqtgF87O0M